Furthermore, it has been found that subjects with type 2 diabetes, either nonobese or obese, show comparable reduced insulin-stimulated glucose utilization when compared with BMI-matched normoglycemic subjects, which is in support for no or only a minor pathogenic role of obesity in initiating insulin resistance and the incidence of type 2 diabetes [101]. The gene discussed is INS; the disease is Insulin resistance.